Alemtuzumab use in clinical practice: recommendations from European multiple sclerosis experts

T Berger, I Elovaara, S Fredrikson, C McGuigan… - CNS drugs, 2017 - Springer
Alemtuzumab (Lemtrada™) is a humanized monoclonal antibody approved in more than 50
countries. Within the European Union, alemtuzumab is indicated for the treatment of adult …

Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment

JJ Grist, BS Marro, DD Skinner… - European journal of …, 2018 - Wiley Online Library
Increasing evidence points to an important role for neutrophils in participating in the
pathogenesis of the human demyelinating disease MS and the animal model EAE …

Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model

RS Khan, K Dine, B Bauman, M Lorentsen, L Lin… - Scientific reports, 2017 - nature.com
The ability of a novel intranasally delivered amnion cell derived biologic to suppress
inflammation, prevent neuronal damage and preserve neurologic function in the …

Tratamento farmacológico da esclerose múltipla: uma revisão atualizada

GC Brito, LJ Oliveira, LB Ferreira… - Acta méd.(Porto …, 2018 - pesquisa.bvsalud.org
Métodos: Realizamos uma busca por artigos de revisão dos últimos 5 anos na base de
dados PubMed. Resultados: Nove drogas foram descritas com base nos seus mecanismos …

Human glutathione s-transferase enzyme gene variations and risk of multiple sclerosis in Iranian population cohort

SP Barjui, S Reiisi - Multiple sclerosis and related disorders, 2017 - Elsevier
Multiple sclerosis (MS) is an inflammatory disease with unknown etiology. Oxidative stress
has been demonstrated to play a role in pathological and inflammatory mechanisms of MS …

[HTML][HTML] Patterns of local site reactions to subcutaneous glatiramer acetate treatment of multiple sclerosis: a clinicopathological study

B Aviv, Z Yaron, A Anat, B Sharon - International journal of clinical …, 2018 - ncbi.nlm.nih.gov
Background: Multiple sclerosis (MS) is a chronic demyelinating disease of the central
nervous system. Glatiramer acetate (GA) is a commonly used immunomodulating drug. It is …

Genetic and molecular biology of multiple sclerosis among iranian patients: an overview

M Moghbeli - Cellular and Molecular Neurobiology, 2020 - Springer
Multiple sclerosis (MS) is one if the common types of autoimmune disorders in developed
countries. Various environmental and genetic factors are associated with initiation and …

Recommendations about multiple sclerosis management during pregnancy, partum and post-partum: consensus position of the portuguese multiple sclerosis study …

S Batista, A Martins da Silva, MJ Sá, L Sousa… - Acta medica …, 2020 - europepmc.org
Multiple sclerosis typically affects young women of reproductive age. Therefore, all
healthcare professionals involved in the follow-up of multiple sclerosis patients must be …

Recomendações sobre a abordagem da esclerose múltipla na gravidez, parto e pós-parto: posição de consenso do Grupo de Estudos de Esclerose Múltipla

S Batista, A Martins da Silva, MJ Sá… - Acta Médica …, 2020 - repositorio.ulisboa.pt
RESUMO A esclerose múltipla afecta tipicamente mulheres jovens em idade reprodutiva.
Desta forma, todo os profissionais de saúde envolvidos no seguimento destes doentes …

Risk Analysis of Specific Environmental Heavy Metals as a Trigger of CD4 & CD8 Among Cases of Multiple Sclerosis: Case-control study.

RA Elberry, R Alazab, A Abdel Hady… - Al-Azhar International …, 2020 - journals.ekb.eg
Background: Environmental pollutants might be among the etiological factors for multiple
sclerosis. The high rise of CD8 and CD4 are the common accepted pathway for the chronic …